G. Esendagli

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Gunes Esendagli, Güneş Esendağlı, G. Esendaglı, Güneş Esendağli, G. Esendagli, Günes Esendagli, Gunes Esendaglı
Publication record
121 papers · 2,328 citations · H-index 28

PAPERS

Development and In Vitro/In Vivo Evaluation of Polymeric Dissolving Microneedle Formulation for Psoriasis Treatment.
20260 citationsauthor #6
Spaceflight alters the immune regulatory functions of neutrophil granulocytes on T lymphocytes
20251 citationsauthor #5
Detection of inflammation and glial cell-related biomarkers in adults with spinal muscular atrophy receiving nusinersen therapy
20250 citationsauthor #5
IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy.
20252 citationsauthor #2
CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders
20250 citationsauthor #12
The impact of aspirin on PD-L1 expression and alteration of M2 polarization in non-small cell lung cancer
20250 citationsauthor #6
Memantine Loaded Micro/Nanoscale Magnetic Motors for the Treatment of Alzheimer’s Disease
20251 citationsauthor #9
CD66b+ Tumor-Infiltrating Neutrophil-like Monocytes as Potential Biomarkers for Clinical Decision-Making in Thyroid Cancer
20253 citationsauthor #12
Immunological Profiling of Thymectomy Tissues in Myasthenia Gravis: The Role of Th17-Related Molecules and Follicular T Helper Cells (P7-11.024)
20250 citationsauthor #10
Refined cuff technique minimizes surgical complexity in rat lung transplantation and improves outcomes
20250 citationsauthor #2
Design, characterization, and in vitro/in vivo evaluation of HER2-targeted immunoliposomes co-functionalized with trastuzumab and iRGD for enhanced delivery of oxaliplatin in gastric cancer therapy
20250 citationsauthor #6
Development and In Vitro and In Vivo Efficacy Investigation of Multifunctional, Targeted, Theranostic Liposomes for Imaging and Photodynamic Therapy of Glioblastoma
20243 citationsauthor #6
An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles
20244 citationsauthor #8
Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis
20243 citationsauthor #4
A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune Signaling
20240 citationsauthor #4
Preparation and In Vitro Characterization of Memantine HCl Loaded PLGA Nanoparticles for Alzheimer’s Disease
20244 citationsauthor #6
Evaluation of Inflammatory and Glial Cell-related Biomarkers in Adults with Spinal Muscular Atrophy Under Nusinersen Treatment (P2-11.003)
20241 citationsauthor #4
Folate Receptor β (FRβ) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles’ Biodistribution in Cancer
20244 citationsauthor #4
Acquired immune resistance is associated with interferon signature and modulation of KLF6/c‐MYB transcription factors in myeloid leukemia
20241 citationsauthor #6
The synthesis and anti-cancer efficacy of endoperoxide modified copper sulfide-ferritin nanocages as PDT and PTT agents
20232 citationsauthor #8
Liver resection modulates hepatic chemokine levels in breast cancer.
20232 citationsauthor #8
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors.
202371 citationsauthor #16
Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After Treatment (P7-8.003)
20230 citationsauthor #4
Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo Evaluation
202323 citationsauthor #5
A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer
202318 citationsauthor #8
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer
202310 citationsauthor #7
Immune checkpoint status and exhaustion‐related phenotypes of CD8+ T cells from the tumor‐draining regional lymph nodes in breast cancer
20232 citationsauthor #8
Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
20234 citationsauthor #9
Pro-fibrogenic and adipogenic aspects of chronic muscle degeneration are contributed by distinct stromal cell subpopulations
20235 citationsauthor #6
Characterization of serum extracellular vesicles and their differential level of miR-197-3p in familial Mediterranean fever patients
20232 citationsauthor #7
Effector Th1 cells under PD‐1 and CTLA‐4 checkpoint blockade abrogate the upregulation of multiple inhibitory receptors and by‐pass exhaustion
20226 citationsauthor #4
Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination
20222 citationsauthor #10
A Novel Combination for the Treatment of Small Cell Lung Cancer: Active Targeted Irinotecan and Stattic Co-Loaded PLGA Nanoparticles.
202222 citationsauthor #5
Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression.
20222 citationsauthor #3
DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY
20220 citationsauthor #1
Functional responsiveness of memory T cells from COVID-19 patients
202129 citationsauthor #5
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes
202130 citationsauthor #12
Proerythroblast Cells of Diamond-Blackfan Anemia Patients With RPS19 and CECR1 Mutations Have Similar Transcriptomic Signature
20213 citationsauthor #5
Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells
202140 citationsauthor #7
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)
20216 citationsauthor #7
Development of curcumin and docetaxel CO-LOADED actively targeted PLGA nanoparticles to overcome blood brain barrier
202123 citationsauthor #8
Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
202123 citationsauthor #5
The effect of leg ischemia/reperfusion injury on the liver in an experimental breast cancer model
20210 citationsauthor #5
A robust optimization approach for the breast cancer targeted design of PEtOx-b-PLA polymersomes.
202110 citationsauthor #10
Cytotoxicity and Biological Compatibility
20210 citationsauthor #3
Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
202121 citationsauthor #8
Protocol to assess the suppression of T-cell proliferation by human MDSC.
202020 citationsauthor #6
229P Can immunogloblun -/+ steroid treatment protect trastuzumab cardiotoxicity, a rabbit model trial
20200 citationsauthor #5
Diagnostic And Therapeutic Evaluation Of Folate-Targeted Paclitaxel And Vinorelbine Encapsulated Theranostic Liposomes For Non-Small Cell Lung Cancer.
202041 citationsauthor #8
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy.
20208 citationsauthor #9
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer
202024 citationsauthor #7
Design and synthesis of novel peptidomimetics for cancer immunotherapy
20201 citationsauthor #10
Aggregation of chitosan nanoparticles in cell culture: reasons and resolutions.
202035 citationsauthor #4
Transcriptional splice variants of CD40 and its prognostic value in breast cancer
20207 citationsauthor #4
Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.
202038 citationsauthor #4
NK and Th17 Cells in The Thymus of Myasthenia Gravis Patients
20200 citationsauthor #7
Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer
202037 citationsauthor #12
CLINICAL RELEVANCE OF POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS (PMN-MDSC) IN AUTOIMMUNE BLISTERING DISORDERS PEMPHIGUS VULGARIS AND BULLOUS PEMPHIGOID.
20203 citationsauthor #7
Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme
202031 citationsauthor #5
Design and in vitro evaluation of folate-targeted, co-drug encapsulated theranostic liposomes for non-small cell lung cancer
202022 citationsauthor #4
Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan.
202023 citationsauthor #4
A method for high-purity isolation of neutrophil granulocytes for functional cell migration assays
20195 citationsauthor #4
Primary tumor resection for initially staged IV breast cancer
20199 citationsauthor #5
Identification of circulating MOG-specific B cells in patients with MOG antibodies
201951 citationsauthor #13
PD‐L2+ wound zone macrophage‐like cells display M1/M2‐mixed activation and restrain the effector Th1 responses
20199 citationsauthor #4
A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet’s Disease
201910 citationsauthor #6
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
2019113 citationsauthor #3
Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
201950 citationsauthor #8
Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer
201928 citationsauthor #5
Efficacy of a novel LyP‐1‐containing self‐microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer
201935 citationsauthor #6
Impact of repeated abdominal surgery on wound healing and myeloid cell dynamics.
20182 citationsauthor #1
Development of novel self-assembled polymeric micelles from partially hydrolysed poly(2-ethyl-2-oxazoline)-co-PEI-b-PCL block copolymer as non-viral vectors for plasmid DNA in vitro transfection
201815 citationsauthor #3
Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation
20183 citationsauthor #5
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody.
201821 citationsauthor #10
Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer
201833 citationsauthor #2
Biomaterial Surface Properties
20181 citationsauthor #2
Dual actions of the antioxidant chlorophyllin, a glutathione transferase P1‐1 inhibitor, in tumorigenesis and tumor progression
201816 citationsauthor #2
Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor-Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study.
20189 citationsauthor #4
Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells
201745 citationsauthor #7
Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis
201722 citationsauthor #8
A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery
201781 citationsauthor #2
A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy
201713 citationsauthor #2
Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
201756 citationsauthor #2
Th1 cells in cancer-associated inflammation
20176 citationsauthor #3
Corrigendum to "The untold story of IFN-γ in cancer biology" [Cytokine Growth Factor Rev. 31 (2016) 73-81].
20174 citationsauthor #2
Atypical Chemokine Receptors in Cancer
20162 citationsauthor #3
Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers
201620 citationsauthor #5
Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells
201669 citationsauthor #5
Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles.
201642 citationsauthor #2
The untold story of IFN-γ in cancer biology.
2016175 citationsauthor #2
CXCL 7-induced macrophage infiltration in lung tumor is independent of CXCR 2 expression
20151 citationsauthor #2
Co‐existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses
201543 citationsauthor #2
Immune system in cancer and hydatid disease: cross‐reactivity vs. immune modulation
20154 citationsauthor #1
Evaluation of Th17 cell infiltration in thymectomy materials of acetycholine receptor antibody-positive myasthenia gravis patients (P7.044)
20150 citationsauthor #4
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes’ stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide
201511 citationsauthor #2
CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors.
201527 citationsauthor #2
CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.
201523 citationsauthor #5
Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma.
201520 citationsauthor #3
Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer
201457 citationsauthor #2
T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands
201429 citationsauthor #2

TIMELINE

2007 5 citations

2008 104 citations

2009 189 citations

2010 19 citations

2011 34 citations

2012 44 citations

2013 89 citations

2014 102 citations

2015 129 citations

2016 308 citations

2017 227 citations

2018 100 citations

2019 310 citations

2020 290 citations

2021 185 citations

2022 32 citations

2023 139 citations

2024 20 citations

2025 7 citations

2026 0 citations

G. Esendagli

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT